📰 Relational Commerce News
Relational Commerce News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Relational Commerce. Real-time updates on events, politics, business and more.
August 22, 2023
Revance Therapeutics, Inc. today announced that the company will host an Investor Day on September 19, 2023, from 9:30 AM ET to 1:00 PM ET. Interested parties can attend the live webcast for the...
August 14, 2023
- Provides Revance entry into the $2.5 billion U.S. therapeutic neuromodulator market.1 - Approval expands the DAXXIFY® label to include efficacy data over the 52-week ASPEN repeat dose clinical... -Today at 08:04 am- MarketScreener
August 9, 2023
- Q2 total revenue of $58.1 million, a YoY increase of 104.9%.- Q2 RHA® Collection revenue of $31.8 million, a YoY increase of 24.7%.- Q2 DAXXIFY® revenue of $22.6 million, a QoQ increase of 47.1%.- Bolstered financial position with $100 million net proceeds from ATM program and $50 million in notes available to be...
August 8, 2023
- Q2 total revenue of $58.1 million, a YoY increase of 104.9%. - Q2 RHA® Collection revenue of $31.8 million, a YoY increase of 24.7%. - Q2 DAXXIFY® revenue of $22.6 million, a QoQ increase of...
May 23, 2023
Revance Therapeutics, Inc. today announced that the company will be participating in the following investor conferences. William Blair 43rd Annual Growth Stock Conference Chief Executive Officer... | May 23, 2023
May 9, 2023
- Q1 total revenue of $49.3 million, a YoY increase of 95.3%. - Q1 RHA® Collection revenue of $30.3 million, a YOY increase of 45.3%. - Q1 DAXXIFY® revenue of $15.4 million, driven by PrevU... | May 9, 2023
March 30, 2023
Revance Therapeutics, Inc. , today announced the release of its 2022 ESG Report, detailing the company’s progress towards its ESG priorities of innovation and access, workplace culture and... | March 30, 2023
November 9, 2022
Received FDA approval for DAXXIFY™ (DaxibotulinumtoxinA-lanm) for injection for the treatment of glabellar linesQ3 total revenue of $29.0 million, a YoY increase of 47% with RHA® Collection revenue of $26.1 million, a YoY increase of 43%Aesthetic accounts across products and services totaled over 4,500 at quarter-en...
October 18, 2022
GuruFocus Article or News written by Business Wire and the topic is about:
October 17, 2022
Revance Appoints David A. Hollander, M.D., M.B.A. as Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace